1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Reduced Apolipoprotein M and Adverse Outcomes across the Spectrum of Human Heart Failure
(
- Contribution to journal › Article
- 2019
-
Mark
Apolipoprotein M induces inhibition of inflammatory responses via the S1PR1 and DHCR24 pathways
(
- Contribution to journal › Article
-
Mark
CFTR Therapeutics Normalize Cerebral Perfusion Deficits in Mouse Models of Heart Failure and Subarachnoid Hemorrhage
(
- Contribution to journal › Article
- 2018
-
Mark
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate
(
- Contribution to journal › Article
- 2010
-
Mark
Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction
(
- Contribution to journal › Article
- 2009
-
Mark
The phosphorylation motif at serine 225 governs the localization and function of sphingosine kinase 1 in resistance arteries
(
- Contribution to journal › Article
- 2005
-
Mark
Vascular function and sphingosine-1-phosphate regulate development of the dorsal pancreatic mesenchyme
(
- Contribution to journal › Article